Skip to content

← All news

Markets

An2 Therapeutics director Robin Readnour sells $212,701 in common stock

1 source ·2 articles ·Aug 19, 22:32 UTC AN2 Therapeutics

Covered by 1 outlet

All coverage · 2 articles

Investing.com Canada ·Aug 19, 22:32 UTC

An2 Therapeutics director Robin Readnour sells $212,701 in common stock

Investing.com News ·Aug 19, 22:30 UTC

An2 Therapeutics director Robin Readnour sells $212,701 in common stock